Literature DB >> 22210103

Guidelines for randomised controlled trials investigating Chinese herbal medicine.

Andrew Flower1, Claudia Witt, Jian Ping Liu, Gudrun Ulrich-Merzenich, He Yu, George Lewith.   

Abstract

UNLABELLED: ETHNOGRAPHIC RELEVANCE: Clinical trials investigating Chinese herbal medicine (CHM) have been frequently criticised for their lack of scientific rigour. As part of the GP-TCM project a team of experienced clinical researchers and CHM practitioners have developed clinical trial guidelines for CHM that combine an appreciation for traditional methods of practice with detailed and practical advice on research methodology.
MATERIALS AND METHODS: This paper presents an executive summary of this work. It introduces the practice of CHM and the key considerations that need to be addressed whilst researching this traditional medical system.
RESULTS: These guidelines emphasise the importance of identifying best practice, and then developing and applying appropriate and rigorous research methodologies to investigate CHM as a whole system.
CONCLUSIONS: It is hoped that this will encourage a thoughtful and meticulous process of investigation that will clarify the contribution that CHM can make to our future healthcare. Innovative new approaches are considered including the application of the new "omic" technologies and systems biology as a way of enhancing our understanding of traditional practice.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210103     DOI: 10.1016/j.jep.2011.12.017

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  29 in total

Review 1.  A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.

Authors:  Bao Yanju; Liping Yang; Baojin Hua; Wei Hou; Zhan Shi; Weidong Li; Conghuang Li; Cihui Chen; Rui Liu; Yinggang Qin; Wenliang Lv
Journal:  Support Care Cancer       Date:  2013-11-26       Impact factor: 3.603

Review 2.  An overview on adverse drug reactions to traditional Chinese medicines.

Authors:  Kelvin Chan; Hongwei Zhang; Zhi-Xiu Lin
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

Review 3.  Recent highlights of Chinese medicine for advanced lung cancer.

Authors:  Xi-Ran He; Shu-Yan Han; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

Review 4.  Which research is needed to support clinical decision-making on integrative medicine?- Can comparative effectiveness research close the gap?

Authors:  Claudia M Witt; Wen-jing Huang; Lixing Lao; Berman Bm
Journal:  Chin J Integr Med       Date:  2012-09-11       Impact factor: 1.978

Review 5.  Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis.

Authors:  Li Ma; Bin Wang; Yuanxiong Long; Hanmin Li
Journal:  Front Med       Date:  2017-03-27       Impact factor: 4.592

6.  Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.

Authors:  Q Wang; Q Wang; S F Wang; L J Jiao; R X Zhang; Y Zhong; J Zhang; L Xu
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

Review 7.  Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage: a systematic review and meta-analysis.

Authors:  Hui-qin Li; Jing-jing Wei; Wan Xia; Ji-huang Li; Ai-ju Liu; Su-bing Yin; Chen Wang; Liang Song; Yan Wang; Guo-qing Zheng; Ji-ping Fan
Journal:  Acta Pharmacol Sin       Date:  2015-05-11       Impact factor: 6.150

Review 8.  The efficacy of Chinese herbal medicine as an adjunctive therapy for advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Shi Guang Li; Hai Yong Chen; Chen Sheng Ou-Yang; Xi-Xin Wang; Zhen-Jiang Yang; Yao Tong; William C S Cho
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 9.  Observational studies on evaluating the safety and adverse effects of traditional chinese medicine.

Authors:  Jung-Nein Lai; Jin-Ling Tang; Jung-Der Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-14       Impact factor: 2.629

Review 10.  The quest for modernisation of traditional Chinese medicine.

Authors:  Qihe Xu; Rudolf Bauer; Bruce M Hendry; Tai-Ping Fan; Zhongzhen Zhao; Pierre Duez; Monique S J Simmonds; Claudia M Witt; Aiping Lu; Nicola Robinson; De-an Guo; Peter J Hylands
Journal:  BMC Complement Altern Med       Date:  2013-06-13       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.